158 related articles for article (PubMed ID: 38384805)
1. A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy.
Zhang H; Sheng S; Qiao W; Han M; Jin R
Front Oncol; 2024; 14():1340286. PubMed ID: 38384805
[TBL] [Abstract][Full Text] [Related]
2. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.
Zhang H; Sheng S; Qiao W; Sun Y; Jin R
Front Oncol; 2024; 14():1395329. PubMed ID: 38800405
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy.
Qiao W; Sheng S; Li J; Jin R; Hu C
J Hepatocell Carcinoma; 2024; 11():509-523. PubMed ID: 38468611
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation.
Qiao W; Li J; Wang Q; Jin R; Zhang H
J Hepatocell Carcinoma; 2024; 11():271-284. PubMed ID: 38333222
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
[TBL] [Abstract][Full Text] [Related]
7. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
Zhang M; Wang Q; Zhang G; Li G; Jin R; Xing H
Front Pharmacol; 2024; 15():1360478. PubMed ID: 38434702
[No Abstract] [Full Text] [Related]
8. Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments.
Qiao W; Xiong Y; Li K; Jin R; Zhang Y
J Hepatocell Carcinoma; 2024; 11():1113-1125. PubMed ID: 38887683
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value and the Ratio Is Negatively Correlated With P38MAPK Expression.
Luo D; Li H; Hu J; Zhang M; Zhang S; Wu L; Han B
Front Oncol; 2020; 10():548744. PubMed ID: 33344225
[TBL] [Abstract][Full Text] [Related]
10. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
Front Oncol; 2022; 12():946531. PubMed ID: 35936698
[TBL] [Abstract][Full Text] [Related]
11. Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram.
Lin Q; Jiang Z; Mo D; Liu F; Qin Y; Liang Y; Cheng Y; Huang H; Fang M
J Hepatocell Carcinoma; 2023; 10():1813-1825. PubMed ID: 37850078
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
13. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Model for Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma Based on Preoperative Serum Prealbumin.
Xu L; Zhao D; Tian P; Ding J; Jiang Z; Ni G; Hou Z; Ni C
J Hepatocell Carcinoma; 2023; 10():2239-2250. PubMed ID: 38107543
[TBL] [Abstract][Full Text] [Related]
15. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.
Zhan G; Peng H; Zhou L; Jin L; Xie X; He Y; Wang X; Du Z; Cao P
Front Endocrinol (Lausanne); 2023; 14():1070396. PubMed ID: 36798659
[TBL] [Abstract][Full Text] [Related]
16. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
17. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy.
Dong W; Yan K; Yu H; Huo L; Xian Z; Zhao Y; Li J; Zhang Y; Cao Z; Fu Y; Cong W; Dong H
Front Oncol; 2020; 10():605057. PubMed ID: 33643907
[TBL] [Abstract][Full Text] [Related]
19. [Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection].
Su J; Wang X; Sun Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):120-130. PubMed ID: 38318906
[TBL] [Abstract][Full Text] [Related]
20. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
